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Objective: To examine the relationship between high-risk human
leukocyte antigen (HLA) genotypes for type 1 diabetes and birth size in
combination with prenatal characteristics in different countries.
Study Design: Four high-risk HLA genotypes were enrolled in the
Environmental determinants of Diabetes in the Young study newborn babies
from the general population in Finland, Germany, Sweden and the United
States. Stepwise regression analyses were used to adjust for country, parental
physical characteristics and environmental factors during pregnancy.
Result: Regression analyses did not reveal differences in birth size
between the four type 1 diabetes high-risk HLA genotypes. Compared with
DQ 4/8 in each country, (1) DQ 2/2 children were heavier in the United
States (P¼0.028) mostly explained however, by parental weight; (2) DQ
2/8 (P¼0.023) and DQ 8/8 (P¼0.046) children were longer in Sweden
independent of parents height and as well as (3) in the United States for
DQ 2/8 (P¼0.023), but again dependent on parental height.
Conclusion: Children born with type 1 diabetes high-risk HLA genotypes
have comparable birth size. Longitudinal follow-up of these children
should reveal whether birth size differences between countries contribute
to the risk for islet autoimmunity and type 1 diabetes.
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Introduction
Height and weight measures in the newborn are inﬂuenced by both
genetic and environmental factors. The health and nutrition status
of the mother are known to inﬂuence the birth size of the baby.
1
Women with increased blood glucose levels give birth to children
with larger birth size.
2,3 Retrospective epidemiological studies have
indicated that young children diagnosed with type 1 diabetes were
heavier or born large for gestational age.
4–7 The impact of genetic
factors on birth size is not fully understood.
8 Some studies have
indicated that the human leukocyte antigen (HLA) system on
chromosome 6 may act on birth size.
9–12 The HLA system
contributes about 50% of the risk for sib-pairs to develop type 1
diabetes.
13,14 The HLA genotypes conferring the highest risk in the
general Caucasian population are limited to the DR3-DQA1*0501-
DQB1*0201/DR4-DQA1*0301-DQB1*0302; DR4-DQA1*0301-DQB1*
0302/DR4-DQA1*0301-DQB1*0302; DR8-DQA1*0401-DQB1*0402/
DR4-DQA1*0301-DQB1*0302 and DR3-DQA1*0501-DQB1*0201/
DR3-DQA1*0501-DQB1*0201 genotypes.
15 Results have been
conﬂicting concerning the possible impact of these HLA-DQ
genotypes on birth weight in the general population. The type 1
diabetes high-risk HLA genotypes have shown an association with
higher birth weight in the general population in Sweden
12 and
Finland.
11 Nevertheless, the same genotypes have shown a
relation to lower birth weight in Norway.
16 To be a carrier
of any of these four genotypes was the criteria for the enrollment
of newborn babies into the Environmental determinants of
Diabetes in the Young (TEDDY) study.
17,18 Maternal smoking
inﬂuences birth size, however it is less established that the resulting
reduction in birth weight may also interact with the HLA-DQ
type of the child.
10 Maternal alcohol consumption was
suggested to impair intrauterine growth but results have been Received 3 December 2010; accepted 1 February 2011; published online 28 April 2011
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19 Furthermore, parental height is related to the birth
length of the baby.
1,8 Taken together, it is necessary to adjust for a
wide range of confounders across different populations to examine
plausible effects of HLA on birth size of newborn babies in the
general population. The aim of this study was, therefore, to
examine the relationship between birth size and type 1 diabetes
high-risk HLA genotypes in combination with prenatal
characteristics in the four different countries of the multinational
TEDDY study.
17,18
Materials and methods
Subjects
Children from the general population were recruited into the
TEDDY study and deﬁned as eligible based on whether they had
any one of the four following high risk genotypes for type 1
diabetes; DR3-DQA1*0501-DQB1*0201/DR4-DQA1*0301-DQB1*
0302 (DQ2/DQ8 or A in TEDDY); DR4-DQA1*0301-DQB1*0302/
DR4-DQA1*0301-DQB1*0302 (DQ8/DQ8 or B in TEDDY); DR8-
DQA1*0401-DQB1*0402/DR4-DQA1*0301-DQB1*0302 (DQ4/DQ8
or C in TEDDY) or DR3-DQA1*0501-DQB1*0201/DR3-DQA1*
0501-DQB1*0201 (DQ2/DQ2 or D in TEDDY; Table 1). The
genotype DQ4/DQ8 is associated with the lowest risk for type 1
diabetes among these four high risk genotypes.
15,20 Therefore, this
genotype was selected as the reference genotype in the multiple
regression models and the risk estimates of the other three
genotypes were based on comparison with this speciﬁc genotype.
Since 1 September 2004 until 31 December 2010, about 350000
newborn children were screened for high risk genotypes for type 1
diabetes in Finland, Germany, Sweden and the United States.
Of these, a total of 8013 newborns were enrolled into the follow-up
study. The blood samples were obtained in the maternity clinics
either as cord blood or dry blood spots on day 3 to 4. If the child
was eligible for the TEDDY study based on the HLA genotype, the
family was contacted by a TEDDY nurse and invited to participate
in a 15-year-follow-up study.
17,18 For our analysis, we included only
children born as singletons, as twins and triplets are known to have
lower birth weight. Children who were ﬁrst-degree relatives to a subject
with type 1 diabetes were excluded in this report. Focusing on babies
whose birth weight ranged from 2 to 6kg and birth length from 40 to
60cm, a total of 5461 children were included in the analyses. However,
paternal height was only available from 1495 children.
The TEDDY study has been approved by Ethical Review Committees
(Finland, Germany, Sweden) and Institutional Review Boards (US)
and all participating families signed an informed consent.
Birth data
Birth weight (g) and birth length (cm) were obtained according
to standard procedures in respective country and recorded on study
forms from hospital records or forwarded by parents. Coordinated
data on prenatal factors, such as country, gestational age,
gestational diabetes, type 1 or type 2 in ﬁrst-degree relatives,
gestational length (weeks), maternal smoking, maternal alcohol
consumption, delivery complication, maternal age when baby was
born, height and weight at end of pregnancy, were recorded on the
ﬁrst clinical visit at 3 months of age. Paternal height was recorded
at the 9-month visit.
HLA typing
HLA genotypes were analyzed using either a genotyping system with
an asymmetric polymerase chain reaction and subsequent
hybridization of allele-speciﬁc probes for HLA-DQA1, DQB1 and
DRB1 as described
21 using DELFIA reagents (Perkin-Elmer,
Waltham, MA, USA) or in a dot blot hybridization assay as detailed
elsewhere.
22 The different analytical methods used by the TEDDY
centers provided accurate results for the genetic risk assessment.
23
Statistical analyses
Birth weight and birth length were reported as mean±standard
deviation, together with the lower and upper quartiles overall and
by country. Univariate analysis was carried out to explore whether
potential confounders such as demographic or prenatal
characteristics differed by either HLA types or birth size (that is,
birth weight and birth length). For HLA types, Pearson’s w
2-test was
used for categorized data and analysis of variance for continuous
data. For birth weight or birth length, two sample t-test or analysis
of variance was used for categorical data and simple regression for
continuous data.
Factors that showed a statistical signiﬁcance in univariate
analysis were considered for multiple regression analysis to
investigate the relationship between birth size and HLA types. In
thist study, birth weight and birth length were examined with
HLA genotypes, respectively, implementing the following four
different models: model (1) unadjusted, model (2) adjusted for
country, sex and gestational length (weeks), model (3) additionally
adjusted for maternal smoking, maternal alcohol consumption,
delivery complication, maternal age at delivery, height and weight
at end of pregnancy, and model (4) additionally adjusted for
Table 1 HLA eligibility for FDR and the GP infants
a
Code Haplotype genotypes Abbreviation GP
A DR4-DQA1*030X-DQB1*0302/DR3-DQA1*0501-DQB1*0201 DQ 2/8 Y
B DR4-DQA1*030X-DQB1*0302/DR4-DQA1*030X-DQB1*0302 DQ 8/8 Y
C DR4-DQA1*030X-DQB1*0302/DR8-DQA1*0401-DQB1*0402 DQ 4/8 Y
D DR3-DQA1*0501-DQB1*0201/DR3-DQA1*0501-DQB1*0201 DQ 2/2 Y
Abbreviations: FDR, ﬁrst degree relative; GP, general population; HLA, human leukocyte
antigen; N, not eligible for the Environmental determinants of Diabetes in the Young
inclusion; Y, eligible.
aDR4 subtyping was used to exclude GP infants with DRB1*0403. DQB1*0304 in place of
DQB1*0302 qualiﬁes subjects for the Environmental determinants of Diabetes in the
Young inclusion. Subtyping was not required to distinguish DQB1*020X and DQA1*030X
subtypes.
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physical characteristics differed by HLA types in the newborns.
Regression parameter estimates and standard errors were
summarized for each model separately.
All statistical analyses were performed using SAS 9.1.3
(SAS Institute, Cary, NC, USA). P-values <0.05 were considered
signiﬁcant.
Results
Birth size, HLA type and demographic characteristics as
univariate parameters
Germany, Sweden and the United States showed similar frequencies
of the four genotypes, the most frequent genotype being DQ 2/8
(40 to 46%), followed by DQ 2/2 (22 to 25%), DQ 8/8 (18 to 22%)
and ﬁnally DQ 4/8 (11 to 16%; Supplementary Table 3-1). The
genotype DQ 4/8 was more frequent in Finland (34%), which
contributed to a signiﬁcant difference in HLA genotypes between
countries (P<0.0001). Babies carrying the DQ 4/8 genotype tended
to be smaller at birth in all countries except in Germany where the
babies carrying this genotype seemed to be largest (Supplementary
Table 2). There was no difference between gender or gestational
length with respect to HLA genotypes (Supplementary Table 3-1).
Prenatal factors and birth length and weight
Children from the United States and Sweden were similar in birth
length, but a lower birth weight on average was observed in the
children from Unites States compared with children from Swedish.
Swedish children were heaviest (Supplementary Table 3-2). Boys
were both heavier (P<0.0001) and longer (P<0.0001) at birth.
Children exposed to maternal smoking had an average birth weight
reduction of 100g compared with children not exposed to smoking.
Maternal alcohol consumption did not seem to inﬂuence birth
weight, but babies born to mothers with moderate alcohol
consumption one to two drinks per month) were longest at birth.
Any delivery complication was associated to an average birth weight
reduction of 80g (Supplementary Table 3-2). Gestational length
was strongly correlated to birth weight (P<0.0001) and more so to
birth length (P<0.0001). As expected, parental height and weight
were signiﬁcantly associated with height and weight of the baby.
Multiple regression models
We examined if there was an effect of HLA genotype with respect to
birth size using multiple regression models. The comparison was
reported as overall and each genotype effect was compared with the
DQ 4/8 genotype.
Birth weight
Overall, the unadjusted and the three different types of adjusted
models failed to detect a difference between HLA genotypes and
birth weight. However, in the United States, model 2 showed that
children carrying the DQ 2/2 genotype were heavier than those
carrying DQ 4/8 if their gender and gestational length were same
(P¼0.028; Supplementary Table 4-2). This trend disappeared in
models 3 and 4 when we additionally adjusted for parental physical
characteristics.
Birth length
Overall, birth length differed by HLA type in model 1, implying that
children with the genotype DQ 4/8 were shorter than those with the
other genotypes (P¼0.009; Supplementary Table 4-1), but the
trend disappeared in adjusted models. In the United States, models
1( P¼0.029) and 2 (P¼0.023) indicated that children with the
genotype DQ 2/8 were longer than those with DQ 4/8
(Supplementary Table 4-2). However, this ﬁnding disappeared in
models adjusted for parental physical characteristics. On the other
hand, Swedish children with the genotypes DQ 2/8 (P¼0.023)
and DQ 8/8 (P¼0.046) were signiﬁcantly longer at birth than the
DQ 4/8 children after adjusting for parental physical characteristics
(model 4; Supplementary Table 4-2).
Inﬂuence from parental physical characteristics
The relationship between parental physical characteristics and HLA
genotypes in the children was further investigated. In the United
States, mothers to children with the genotype DQ 2/2 were heavier
compared with mothers to the DQ 4/8 children (P¼0.009;
Table 2a). Moreover, mothers of children who carried the genotype
DQ 2/8 (P¼0.040) or DQ 2/2 (P¼0.001) were taller than those
with DQ 4/8 (Table 2b). Overall, fathers of children that carried the
genotype DQ 2/2 were also taller than those with DQ 4/8
(P¼0.003; Table 2b). When separated for the participating
countries, this ﬁnding was signiﬁcant only in the United States
(P¼0.015). However, in Sweden, maternal weight at the end of
pregnancy was lower in mothers to babies carrying the genotype
DQ 2/8 than those with DQ 4/8 (P¼0.041; Table 2a).
Discussion
The major most important ﬁnding in this study was that newborns
with the four type 1 diabetes high-risk HLA genotypes did not differ
in birth size following the stepwise regression analysis. This is
important as these children with type 1 diabetes high-risk HLA
genotypes will be followed for 15 years for the development of islet
autoimmunity and type 1 diabetes.
17,18 It is an advantage that the
children enrolled in the TEDDY study would be comparable at
baseline with respect to birth size. Several epidemiological studies
4,5
including meta-analyses
24 have suggest that children developing
type 1 diabetes were born large for gestational age. This
relationship has not been understood. One possible explanation
was that children were born large for gestational age because of
gestational infections.
25 An alternative explanation was that HLA
genotypes conferring risk of type 1 diabetes were strongly associated
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12 alone, or in combination with
possible gestational infection.
26 Furthermore, we can not exclude
that the present newborns carrying the four type 1 diabetes high-
risk HLA genotypes had increased birth weight and length
compared with newborns with low-risk HLA genotypes. The fact
that parental weight and height most likely explained some of the
differences in birth weight (Finland and Unites States) and length
(United States but not Sweden) underscore the possible importance
of country-speciﬁc environmental determinants of birth sizes. The
dissimilar country-speciﬁc sub-structure of the four HLA genotypes
will be taken into account as the TEDDY children are followed
prospectively for the development of islet autoimmunity and
type 1 diabetes.
17,18
The second major ﬁnding was that Swedish DQ 2/8 and DQ 8/8
children were longer than the DQ 4/8 children used as a reference
group. This observation, which was independent of parental weight
and height, was a conﬁrmation of the observation that DQ2/8 was
associated with an increase relative birth weight
12 and length.
26 It
is noted that the Swedish population frequency of DQ4/8 (1.4%) is
half of that of DQ2/8 (3.5%). However, among children developing
type 1 diabetes before 18 years of age, the DQ2/8 (30%) is more
common than the DQ4/8 (5%) genotype.
27 Finnish babies more
often carried the DQ 4/8 genotype, whereas DQ2/8 children were
less frequent compared with the other countries. The shorter
Finnish babies compared with the other countries could indicate
either a lesser exposure or a different reaction to gestational
infections.
9 HLA DQ-DR seems to contribute less to the risk of
type 1 diabetes compared with 20 years ago since the frequency of
the high risk genotypes in type 1 diabetes patients has decreased
over time
20,28–30 at the same time as the incidence of type 1
diabetes has increased.
24
Our observations support the view that environmental factors in
pregnancy as well as in early childhood may contribute to type 1
diabetes risk. For example, in young children an increased growth,
independent of HLA types, was observed before the diagnosis of
type 1 diabetes.
31 Several factors could either support or dismiss the
accelerator hypothesis,
32 such as feeding behaviors in early
childhood
33 or postnatal exposure to viruses that might alter the
Table 2a Mother height and weight at the end of pregnancy with TEDDY HLA types
TEDDY HLA genotype Height (cm) Weight at the end of pregnancy (kg)
n PE s.e. Pr>|t| Pr>F n PE s.e. Pr>|t| Pr>F
Overall
AvsC 0.680 0.264 0.010** 1.130 0.578 0.051*
BvsC 5328 0.446 0.302 0.140 0.001** 5255 0.853 0.662 0.198 <0.0001**
DvsC 1.140 0.298 0.000** 3.145 0.652 <0.0001**
United States
AvsC 1.056 0.514 0.040** 1.644 1.134 0.148
BvsC 2023 1.059 0.576 0.066* 0.012** 2007 0.844 1.274 0.508 0.042**
DvsC 1.846 0.558 0.001** 3.246 1.234 0.009**
Finland
AvsC  0.018 0.435 0.967 0.148 0.892 0.869
BvsC 1128 0.064 0.544 0.906 0.999 1122  0.297 1.116 0.790 0.544
DvsC 0.017 0.555 0.975 1.452 1.138 0.202
Germany
AvsC 0.904 1.252 0.471 4.153 2.979 0.164
BvsC 275 0.943 1.420 0.507 0.131 274 5.397 3.376 0.111 0.216
DvsC 2.700 1.346 0.046** 6.576 3.201 0.041**
Sweden
AvsC 0.273 0.445 0.539  2.026 0.990 0.041**
BvsC 1902  0.372 0.492 0.450 0.228 1852  2.033 1.093 0.063* 0.017**
DvsC 0.440 0.493 0.372 0.150 1.098 0.892
Abbreviations: HLA, human leukocyte antigen; PE, multiple regression parameter estimate; Pr>|t|, P-value for parameter estimate; Pr>F, P-value for analysis of covariance; TEDDY, the
Environmental determinants of Diabetes in the Young.
Additionally adjusted for parental physical characteristics; **P<0.05; *P<0.1.
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34 The ﬁnding that maternal smoking in all
countries conferred a weight reduction is in accordance with results
from previous studies.
10,35
An association between increased birth weight and later
development of type 1 diabetes seems to be well established.
6,36 A
relationship between increased birth size and HLA high risk
genotypes for type 1 diabetes has also been reported.
12 The strength
of this study is the number of type 1 diabetes high risk participants
and coordinated data in different countries. One limitation with
our study is that we do not have data on low risk genotype children
from the general population. However, most prediction studies of
type 1 diabetes focus on subjects carrying any of the high-risk
genotypes. In addition, we have not studied other genetic factors
besides HLA that might inﬂuence intrauterine growth such as
variants of melanocortin 4 receptor regulating energy
homeostasis,
37 variants of the insulin gene,
38–41 variants of ADCY5,
one of the enzymes synthesizing cyclic adenosine monophosphate
or CCN1 thought to be involved in pre-mRNA splicing and RNA
processing.
8
In conclusion, different factors inﬂuence birth size in different
countries. In the United States, birth size was mostly because of the
parental height and maternal weight at delivery. In Sweden, HLA
genotype seemed to inﬂuence birth length. The variability in birth
size between countries in children selected to have the same type 1
diabetes high risk HLA genotypes suggest that environmental
factors, non-HLA genetic variants, or both may be related to the
subsequent risk of islet autoimmunity and type 1 diabetes in these
children.
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